BDNF and Alzheimer disease: The qRT-PCR results showed that the combined effect of AD-MSCs with tacrolimus significantly increased the expression of BDNF, glial-derived growth factor (GDNF), and NGF genes, particularly at concentrations ranging from 1 to 10 ng/mL.